| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 655.82M | 612.97M | 557.22M | 559.78M | 610.35M |
| Gross Profit | 288.47M | 227.25M | 175.90M | 154.19M | 157.09M |
| EBITDA | 99.92M | 60.92M | 99.32M | 83.33M | 56.00M |
| Net Income | 58.82M | 34.07M | 56.92M | 42.00M | 18.09M |
Balance Sheet | |||||
| Total Assets | 524.52M | 476.53M | 484.76M | 475.21M | 522.81M |
| Cash, Cash Equivalents and Short-Term Investments | 173.23M | 105.61M | 114.15M | 104.63M | 110.13M |
| Total Debt | 16.44M | 25.32M | 35.54M | 50.94M | 120.37M |
| Total Liabilities | 147.13M | 151.05M | 176.84M | 207.56M | 276.48M |
| Stockholders Equity | 377.80M | 325.91M | 308.37M | 267.88M | 246.50M |
Cash Flow | |||||
| Free Cash Flow | 72.90M | 25.91M | 57.76M | 47.41M | -20.06M |
| Operating Cash Flow | 81.86M | 48.35M | 76.45M | 67.72M | 59.99M |
| Investing Cash Flow | 26.48M | -20.00M | -17.16M | -19.38M | -79.93M |
| Financing Cash Flow | -49.07M | -32.04M | -39.27M | -43.63M | -56.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.05B | 6.73 | 36.38% | 4.07% | 40.39% | 81.74% | |
72 Outperform | HK$493.57M | 7.81 | 15.49% | 2.76% | 6.99% | 72.73% | |
62 Neutral | HK$2.79B | 9.26 | 8.16% | 4.75% | -3.18% | -36.46% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | HK$416.81M | 17.23 | 1.68% | ― | -7.94% | 33.02% | |
46 Neutral | HK$46.33M | -2.36 | -19.08% | ― | -10.04% | 27.35% | |
45 Neutral | HK$179.28M | -2.32 | -7.19% | ― | 34.08% | -112.24% |